All In Biotech

Free tool

FAERS Monitor: Emend

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021549 or its brand name (Emend, Aprepitant). Reports on generic versions are filed under their own applications.

Reports

19,186

Serious

17,114

89% of reports

Hospitalization

10,508

Death reported

3,248

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea2,321
  • fatigue2,054
  • pyrexia1,734
  • dyspnoea1,696
  • diarrhoea1,674
  • vomiting1,605
  • off label use1,489
  • alopecia1,412
  • rash1,330
  • hypersensitivity1,248
  • decreased appetite1,172
  • pruritus1,138
  • febrile neutropenia1,126
  • infusion related reaction1,112
  • pain1,097

Reports by year received

View as table
YearReports
2004127
2005134
2006145
2007181
2008177
2009216
2010351
2011479
2012764
2013691
2014818
20151,057
20161,325
2017894
20181,376
20191,393
20201,186
20211,275
20221,170
20231,246
20241,848
20251,439
2026894

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,034,973 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
febrile neutropeniaSignal1,12618.917.918,821
infusion related reactionSignal1,11218.717.618,344
alopeciaSignal1,4127.97.58,566
hypersensitivitySignal1,2487.47.06,933
decreased appetiteSignal1,1725.65.34,399
pyrexiaSignal1,7345.55.36,482
vomitingSignal1,6053.83.63,299
rashSignal1,3303.43.22,232
dyspnoeaSignal1,6963.33.12,769
pruritusSignal1,1383.33.11,801
nauseaSignal2,3213.23.13,681
fatigueSignal2,0542.92.82,641
diarrhoeaSignal1,6742.82.72,063
pain1,0972.01.8529
off label use1,4891.91.8622

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.